Price $25.82 |
Market Cap
1.25B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.15
|
P/S
88.65
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-309.5K
|
FCF
-5.7
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-20.70%
|
ROI
-22.80%
|
|
ROA
-18.50%
|
EPS Growth
-119.10%
|
Current Ratio
13.3
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Acorda Therapeutics Inc (ACOR) | $0.59 | - | - | 14M | Strong Buy |
| ADM Tronics Unlimited, Inc. (ADMT) | $0.10 | - | - | 8.1M | Strong Buy |
| Akebia Therapeutics Inc (AKBA) | $1.13 | - | - | 103.8M | Strong Buy |
| Applied DNA Sciences Inc (APDN) | $1.04 | - | - | 14.8M | Strong Buy |
| Aquestive Therapeutics Inc (AQST) | $2.24 | - | - | 63.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
